Utility of transient elastography in the non‐invasive evaluation of cystic fibrosis liver disease. (22nd February 2013)
- Record Type:
- Journal Article
- Title:
- Utility of transient elastography in the non‐invasive evaluation of cystic fibrosis liver disease. (22nd February 2013)
- Main Title:
- Utility of transient elastography in the non‐invasive evaluation of cystic fibrosis liver disease
- Authors:
- Kitson, Matthew T.
Kemp, William W.
Iser, David M.
Paul, Eldho
Wilson, John W.
Roberts, Stuart K. - Abstract:
- <abstract abstract-type="main" id="liv12113-abs-0001"> <title>Abstract</title> <sec id="liv12113-sec-0001" sec-type="section"> <title>Background</title> <p>Liver disease frequently complicates cystic fibrosis (CF), with CF liver disease (CFLD) a leading cause of death. Liver biopsy is rarely performed because of the patchy nature of the disease. Transient elastography can reliably stage liver fibrosis via liver stiffness measurement (LSM).</p> </sec> <sec id="liv12113-sec-0002" sec-type="section"> <title>Aims</title> <p>To evaluate LSM as a diagnostic tool in adults with CFLD.</p> </sec> <sec id="liv12113-sec-0003" sec-type="section"> <title>Methods</title> <p>Fifty adult patients with CF were prospectively studied: 25 with CFLD and 25 without CFLD. The presence of CFLD and portal hypertension (PHT) was assessed according to strict established criteria based on serial biochemistry and imaging. All patients underwent LSM; APRI, Hepascore<sup>®</sup> and Forns score were calculated.</p> </sec> <sec id="liv12113-sec-0004" sec-type="section"> <title>Results</title> <p>Median LSM was higher in those with CFLD [8.1 kPa (IQR 6.8–9.5) vs. 5.0 kPa (IQR 4.1–5.6); <italic>P</italic> &lt; 0.001]. On multivariate analysis, LSM was the only variable associated with CFLD (OR 2.74, 95% CI 1.53–4.89; <italic>P</italic> = 0.001). AUROC for LSM predicting CFLD was 0.87 (95% CI 0.77–0.98) and an LSM ≥6.8 kPa predicted CFLD with 76.0% sensitivity and 92.0% specificity. Median LSM was higher in<abstract abstract-type="main" id="liv12113-abs-0001"> <title>Abstract</title> <sec id="liv12113-sec-0001" sec-type="section"> <title>Background</title> <p>Liver disease frequently complicates cystic fibrosis (CF), with CF liver disease (CFLD) a leading cause of death. Liver biopsy is rarely performed because of the patchy nature of the disease. Transient elastography can reliably stage liver fibrosis via liver stiffness measurement (LSM).</p> </sec> <sec id="liv12113-sec-0002" sec-type="section"> <title>Aims</title> <p>To evaluate LSM as a diagnostic tool in adults with CFLD.</p> </sec> <sec id="liv12113-sec-0003" sec-type="section"> <title>Methods</title> <p>Fifty adult patients with CF were prospectively studied: 25 with CFLD and 25 without CFLD. The presence of CFLD and portal hypertension (PHT) was assessed according to strict established criteria based on serial biochemistry and imaging. All patients underwent LSM; APRI, Hepascore<sup>®</sup> and Forns score were calculated.</p> </sec> <sec id="liv12113-sec-0004" sec-type="section"> <title>Results</title> <p>Median LSM was higher in those with CFLD [8.1 kPa (IQR 6.8–9.5) vs. 5.0 kPa (IQR 4.1–5.6); <italic>P</italic> &lt; 0.001]. On multivariate analysis, LSM was the only variable associated with CFLD (OR 2.74, 95% CI 1.53–4.89; <italic>P</italic> = 0.001). AUROC for LSM predicting CFLD was 0.87 (95% CI 0.77–0.98) and an LSM ≥6.8 kPa predicted CFLD with 76.0% sensitivity and 92.0% specificity. Median LSM was higher in those with PHT [15.7 kPa (IQR 9.2–17.2) vs. 5.4 kPa (IQR 4.3–6.8); <italic>P</italic> &lt; 0.001]. The AUROC for LSM predicting the presence of PHT was 0.96 (95% CI 0.92–1.00). An LSM cut‐off of ≥8.9 kPa predicted the presence of PHT with 87.5% sensitivity, 90.5% specificity, 63.6% positive predictive value and 92.9% negative predictive value.</p> </sec> <sec id="liv12113-sec-0005" sec-type="section"> <title>Conclusions</title> <p>LSM is an accurate and reliable non‐invasive tool in assessing CFLD and PHT. An LSM ≥6.8 kPa is highly suggestive of CFLD and an LSM &lt;8.9 kPa reliably excludes PHT.</p> </sec> </abstract> … (more)
- Is Part Of:
- Liver international. Volume 33:Number 5(2013:May)
- Journal:
- Liver international
- Issue:
- Volume 33:Number 5(2013:May)
- Issue Display:
- Volume 33, Issue 5 (2013)
- Year:
- 2013
- Volume:
- 33
- Issue:
- 5
- Issue Sort Value:
- 2013-0033-0005-0000
- Page Start:
- 698
- Page End:
- 705
- Publication Date:
- 2013-02-22
- Subjects:
- Liver -- Periodicals
Liver -- Diseases -- Periodicals
616.362 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1478-3231 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/liv.12113 ↗
- Languages:
- English
- ISSNs:
- 1478-3223
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5280.514000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3897.xml